Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 1, 2017
The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group studySuna Cokmert, Ozgur Tanriverdi, Inanc Karapolat, et al.Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2014
Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?Lutfiye Demir, Seyran Yigit, Canan Sadullahoglu, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancerSuna Cokmert, Lutfiye Demir, Alper Can, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 28, 2017
The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancerBetul Bolat Kucukzeybek, Ibrahim Vedat Bayoglu, Yuksel Kucukzeybek, et al.Journal of Cancer Research and Therapeutics|April 12, 2013
Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literatureLutfiye Demir, Alper Can, Rukiye Oztop, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 12, 2020
Prognostic role of De Ritis and basal neutrophil to lymphocyte ratio in patients with advanced stage pancreatic cancer [Izmir Oncology Group (IZOG) Study]Umut Varol, Ezgi Kaya, Utku Oflazoglu, et al.Frontiers in Nutrition|September 5, 2022
HALP score and GNRI: Simple and easily accessible indexes for predicting prognosis in advanced stage NSCLC patients. The İzmir oncology group (IZOG) studyZeynep Gülsüm Güç, Ahmet Alacacıoğlu, Mehmet Eren Kalender, et al.Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients?Cigdem Erten, Lutfiye Demir, Isil Somali, et al.Indian Journal of Pathology & Microbiology|August 15, 2014
The prognostic significance of bone marrow metastases: evaluation of 58 casesBetul Bolat Kucukzeybek, Aylin Orgen Calli, Yuksel Kucukzeybek, et al.Medical Oncology (Northwood, London, England)|March 6, 2014
Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancerAhmet Dirican, Yuksel Kucukzeybek, Ahmet Alacacioglu, et al.Pageof 6